ArcherDX will perform whole exome sequencing of NSCLC patient samples to generate personalised ctDNA assays to test for MRD
News
WHO pauses hydroxycholoroquine arm in COVID-19 trial
The Solidarity trial’s expert group will review all evidence available on the drug
Gov’t unveils coronavirus antibody testing scheme
10 million tests have so far have been secured in a ‘landmark deal’ with industry, including Roche Diagnostics and Abbott Labs
Gov’t invests £7m in patient recruitment centres for clinical research
The sites will be managed by the National Institute for Health Research (NIHR) and run by NHS trusts
GSK partners with Samsung to expand biopharma manufacturing
Samsung will provide GSK with additional flexible capacity for large-scale biopharmaceutical product manufacturing
NICE u-turn backs Roche’s Tecentriq for triple negative breast cancer
Tecentriq is the first and only immune checkpoint inhibitor which has been deemed a cost effective use of NHS resources for this patient group
Researchers investigate impact of lockdown on musculoskeletal conditions
The research will focus on people with psoriatic arthritis, axial spondyloarthritis and chronic pain conditions such as fibromyalgia
First UK healthcare worker to enrol in COVID-19 prevention trial
Over 130 UK frontline healthcare workers have lost their lives during the pandemic
UK risks second surge of coronavirus without clarity on test, track and trace
The NHS Confederation is calling on the government for a clear strategy before lockdown measures are further lifted
AZ/MSD’s Lynparza wins prostate cancer approval
Lynparza is the only PARP inhibitor to improve overall survival versus enzalutamide or abiraterone in prostate cancer patients with BRCA1/2 or ATM mutations
People with diabetes at higher risk of amid pandemic
The overall death rate for people with diabetes doubled during the early stage of the pandemic
Roche partners with Vividion on novel E3 Ligases
The deal could be worth ‘several billions of dollars’ to the US biotech
COVID-19 related delays to cancer treatment could cost thousands of lives, research shows
Research shows that a delay of three months across all 94,912 patients who would have had surgery to remove their cancer over one year would lead to an additional 4,755 deaths
EU approves Novartis’ SMA gene therapy Zolgensma
Discussions with EU governments and reimbursement agencies are ongoing to agree on terms of an innovative ‘Day One’ access programme
Ergomed teams up with Automation Anywhere and DataRobot
The move is designed to accelerate the company’s intelligent automation strategy
